905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

Hematological symptom burden and treatment patterns in patients with IgG4 related disease A real world multicenter retrospective analysis

Iron deficiency anemia and health equity Persistent gaps among reproductive age women in the United States

A propensity matched analysis of real world outcomes comparing direct oral anticoagulants and warfarin in patients diagnosed with portal vein thrombosis

National trends and demographic disparities in perinatal non traumatic intracranial hemorrhage mortality in the United States 1999–2024

Hematologic toxicities associated with PARP inhibitors Real world pharmacovigilance updated study using faers database with era trend evaluation and serious outcome modeling

Real world use of prophylaxis in people with non severe hemophilia in the United States Insights from the athn transcends Study hemophilia natural history arm

Systematic review and meta analysis of randomized controlled trials on outpatient thromboprophylaxis OTP in patients with cancers with khorana score KS ≥ 2 receiving chemotherapy

Social vulnerability predicts higher county level pulmonary embolism mortality in the United States A 2016 2020 nationwide analysis

Fostamatinib significantly increases risk of hypertension in hematologic patients A meta analysis of randomized trials

Rapid decrease in age adjusted mortality rates associated with ITP following eltrombopag aand romiplostin approvals but not in TMA following eculizumab approval 1999 2023

Clinical and economic burden of steroids in primary immune thrombocytopenia A real world italian analysis

Patient perspectives on the burden of hypereosinophilic syndrome Results from the Phase 3 natron interview sub study

Evaluation of medical provider practice patterns in the assessment and management in heavy menstrual bleeding for patients on anticoagulation

Investigating patients experiences with dyspnea associated with warm antibody hemolytic anemia wAIHA and cognitive debriefing of the FACIT dyspnea 10 item short form A qualitative patient interview study

Outcomes of splenectomy in benign and malignant hematologic conditions in the immunotherapy era

Real world treatment patterns for Hemophilia A since the launch of emicizumab in the US

Increased age adjusted mortality rates from hemophagocytic lymphohistiocytosis HLH 2010 2023

Treatment patterns and outcomes among warm autoimmune hemolytic anemia patients receiving rituximab in the United States A retrospective database study

Reducing premedication use with intravenous iron in the outpatient setting A quality improvement project

A comparison of intravenous iron formulations for treating iron deficiency anemia after bariatric surgery

Prognostic consequences of delayed treatment in severe aplastic anemia A challenge in resource constrained healthcare systems

Disease monitoring and management among pediatric patients with pyruvate kinase deficiency Real world practices from pyruvate kinase deficiency registries prior to 2024 international expert guidelines

Safety of ravulizumab use in pregnancy Insights from a global pharmacovigilance analysis